Table 2.
Class | Daily dosage (mg) Mean ± SD (min-max) |
Patients under treatment # (%) |
---|---|---|
Biguanides | ||
Metformin | 1,605 ± 743 (500–2,550) | 10 (100) |
Sulfonylureas | ||
Glibenclamide | 33 ± 18 (15–50) | 2 (20) |
Gliclazide | 60 ± 0 (NA) | 2 (20) |
DPP-4 inhibitors | ||
Sitagliptin | 100 ± 0 (NA) | 1 (10) |
SGLT2 inhibitors | ||
Empagliflozin | 25 ± 0 (NA) | 2 (20) |